184 related articles for article (PubMed ID: 32176312)
21. A retrospective histopathological survey on canine lymphomas subtypes of Porto District.
Pinello K; Santos M; Dias-Pereira P; Niza-Ribeiro J; de-Matos A
Open Vet J; 2023 Apr; 13(4):443-450. PubMed ID: 37251261
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
Fosmire SP; Thomas R; Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Smith TL; Gardner LA; Ritt MG; Bell JS; Freeman KP; Greenfield BE; Lana SE; Kisseberth WC; Helfand SC; Cutter GR; Breen M; Modiano JF
Vet Pathol; 2007 Jul; 44(4):467-78. PubMed ID: 17606508
[TBL] [Abstract][Full Text] [Related]
23. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
[TBL] [Abstract][Full Text] [Related]
24. Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.
Meichner K; Fogle JE; English L; Suter SE
J Vet Intern Med; 2016 May; 30(3):819-26. PubMed ID: 27013187
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
Milner RJ; Pearson J; Nesbit JW; Close P
Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
[TBL] [Abstract][Full Text] [Related]
26. Application of Immunophenotyping and Heteroduplex Polymerase Chain Reaction (hPARR) for Diagnosis of Canine Lymphomas.
Sirivisoot S; Techangamsuwan S; Tangkawattana S; Rungsipipat A
Asian Pac J Cancer Prev; 2016; 17(6):2909-16. PubMed ID: 27356711
[TBL] [Abstract][Full Text] [Related]
27. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
28. The role of rituximab in the treatment of canine lymphoma: an ex vivo evaluation.
Impellizeri JA; Howell K; McKeever KP; Crow SE
Vet J; 2006 May; 171(3):556-8. PubMed ID: 16624725
[TBL] [Abstract][Full Text] [Related]
29. Expression of vascular endothelial growth factor and its receptors in canine lymphoma.
Wolfesberger B; Guija de Arespacohaga A; Willmann M; Gerner W; Miller I; Schwendenwein I; Kleiter M; Egerbacher M; Thalhammer JG; Muellauer L; Skalicky M; Walter I
J Comp Pathol; 2007 Jul; 137(1):30-40. PubMed ID: 17467003
[TBL] [Abstract][Full Text] [Related]
30. A novel NF-κB inhibitor improves glucocorticoid sensitivity of canine neoplastic lymphoid cells by up-regulating expression of glucocorticoid receptors.
Matsuda A; Tanaka A; Muto S; Ohmori K; Furusaka T; Jung K; Karasawa K; Okamoto N; Oida K; Itai A; Matsuda H
Res Vet Sci; 2010 Dec; 89(3):378-82. PubMed ID: 20362310
[TBL] [Abstract][Full Text] [Related]
31. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
[TBL] [Abstract][Full Text] [Related]
32. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma.
Lucas SR; Maranhão RC; Guerra JL; Coelho BM; Barboza R; Pozzi DH
Vet Comp Oncol; 2015 Sep; 13(3):184-93. PubMed ID: 23615221
[TBL] [Abstract][Full Text] [Related]
33. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
34. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
35. Treatment of T cell lymphoma in dogs.
Moore AS
Vet Rec; 2016 Sep; 179(11):277. PubMed ID: 27634860
[TBL] [Abstract][Full Text] [Related]
36. Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression.
Martini V; Cozzi M; Aricò A; Dalla Rovere G; Poggi A; Albonico F; Mortarino M; Ciusani E; Aresu L; Comazzi S
Vet Immunol Immunopathol; 2017 May; 187():14-19. PubMed ID: 28494924
[TBL] [Abstract][Full Text] [Related]
37. Tumour-specific microRNA expression pattern in canine intestinal T-cell-lymphomas.
Joos D; Leipig-Rudolph M; Weber K
Vet Comp Oncol; 2020 Dec; 18(4):502-508. PubMed ID: 31997569
[TBL] [Abstract][Full Text] [Related]
38. Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.
Zwingenberger AL; Kent MS; Shi C; Taylor SL; Chen X; Lam KS
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):298-304. PubMed ID: 22177114
[TBL] [Abstract][Full Text] [Related]
39. Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Calvalido J; Wood GA; Mutsaers AJ; Wood D; Sears W; Woods JP
Vet Immunol Immunopathol; 2016 Dec; 182():106-114. PubMed ID: 27863540
[TBL] [Abstract][Full Text] [Related]
40. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma.
Al-Nadaf S; Rebhun RB; Curran KM; Venable RO; Skorupski KA; Willcox JL; Burton JH
BMC Vet Res; 2018 Nov; 14(1):356. PubMed ID: 30458771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
